Document is current
Any future updates will be listed below
-
Authors
Zhang, Yuefeng
Zhao, Qifeng
Du, Jie
- License Information
-
More Information
Article History
Received: 11 July 2025
Accepted: 27 August 2025
First Online: 30 September 2025
Declarations
:
: The esophageal cancer cell line ECA109 used in this study was legally and commercially procured from ATCC. This study was conducted with approval from the Ethics Committee of The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University. This study was conducted in accordance with the declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
